2m 2m 2m 2m 2m 2m 2m
United Therapeut (UTHR)
NASDAQ
$531.77-$3.80 (-0.71%)
Price as of Jul 13, 2026 7:56 PM EDT- $23.2BMarket Cap
- 79.91%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
United Therapeut (UTHR)
$531.77-$3.80 (-0.71%)
UTHR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $535.57 | ||
Change | -$11.49 (-2.10%) | ||
Open | $541.47 | ||
High | $543.05 | ||
Low | $530.09 | ||
Previous Close | $547.06 | ||
Volume | 303,818 | ||
30-Day Average Volume | 562,930 | ||
1-Week Change | -2.13% | ||
1-Month Change | -1.90% | ||
1-Year Change | 79.91% | ||
3-Year Change | 133.05% | ||
5-Year Change | 191.78% | ||
Fundamentals | |||
Shares Outstanding | 42.4M | ||
Total Assets | $6.7B | ||
Market Cap | $23.2B | ||
Enterprise Value | $22.1B | ||
Period: QTR TTM FY | |||
Revenue | $781.5M | ||
Net Income | $274.9M | ||
Free Cash Flow | $362.5M | ||
EBIT | $318.3M | ||
EBITDA | $340.9M | ||
Net Working Capital | $2.3B | ||
EPS | $5.82 | ||
Enterprise Value/EBITDA | 65 | ||
Enterprise Value/Revenue | 28 | ||
P/B | 4 | ||
P/E | 94 | ||
PEG | -4 | ||
Price/Free Cash Flow | 64 | ||
Price/Operating Cash Flow | 50 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue